// App-Quantinova.ai

52 : Neutrophil-to-lymphocyte ratio (NLR) as a prognostic indicator of treatment response to novel hormones in metastatic castrate-resistant prostate cancer: Real-world data from a single institution.

Researchers

Presenter

  • Emily Scott

Principal Investigators

  • Katia Pasciuti

  • Magdalena Kubiak

  • Gillian Marks

  • Sarah Needleman

  • Kate Smith

  • Mark Prentice

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Neutrophil lymphocyte ratio

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved